| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Sato Vicki L is a Director at Vir Biotechnology, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $17.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $18.42 | $30,687.72 | -1.3% | -2.9% | +17.0% | |
| Dec 15, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $23.39 | $38,967.74 | -1.3% | -13.9% | +0.1% | |
| Nov 15, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $19.13 | $31,870.58 | -1.3% | -7.7% | +54.0% | |
| Oct 16, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $20.66 | $34,419.56 | -1.3% | -11.5% | +29.4% | |
| Sep 15, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $23.62 | $39,347.60 | -0.6% | -1.6% | +30.7% | |
| Aug 15, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $24.30 | $40,483.80 | -1.3% | -33.3% | -7.5% | |
| Jul 17, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $29.60 | $49,313.60 | -1.2% | -29.7% | -18.8% | |
| Jun 30, 2023 | VIR Vir Biotechnology, Inc. | Director | Sell | 18,000 | $24.66 | $443,916.00 | -1.3% | -62.5% | -63.7% | |
| Jun 28, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,666 | $29.84 | $49,709.32 | -0.6% | -28.7% | -23.4% | |
| Mar 8, 2023 | VIR Vir Biotechnology, Inc. | Director | Sell | 17,935 | $22.59 | $405,061.98 | -1.3% | +14.9% | -50.3% |